PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.35%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.35%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-9.39%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-9.39%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
0.85%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
-3.57%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-3.57%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-4.27%
Share reduction while ADI is at 1.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-4.27%
Reduced diluted shares while ADI is at 0.41%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
1.64%
Dividend growth of 1.64% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
133.53%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
2372.73%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
-12.84%
Negative 10Y revenue/share CAGR while ADI stands at 143.22%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
44.05%
5Y revenue/share CAGR at 50-75% of ADI's 79.50%. Martin Whitman would worry about a lagging mid-term growth trajectory.
27.18%
3Y revenue/share CAGR at 50-75% of ADI's 36.87%. Martin Whitman would question if the firm lags behind competitor innovations.
90.99%
10Y OCF/share CAGR under 50% of ADI's 1108.09%. Michael Burry would worry about a persistent underperformance in cash creation.
16.19%
Below 50% of ADI's 298.02%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
160.94%
3Y OCF/share CAGR under 50% of ADI's 367.62%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-16.62%
Negative 10Y net income/share CAGR while ADI is at 780.82%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-293.74%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-187.06%
Negative 3Y CAGR while ADI is 211.35%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
419.26%
10Y equity/share CAGR at 75-90% of ADI's 509.33%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
175.56%
5Y equity/share CAGR at 50-75% of ADI's 325.74%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
158.15%
3Y equity/share CAGR 1.25-1.5x ADI's 121.42%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
28.19%
Dividend/share CAGR of 28.19% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
6.92%
Dividend/share CAGR of 6.92% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
54.74%
3Y dividend/share CAGR of 54.74% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-17.32%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-16.56%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.51%
Asset growth above 1.5x ADI's 1.16%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
7.46%
BV/share growth above 1.5x ADI's 3.96%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.19%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
6.70%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-3.53%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.